Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Just For You Momentum Is Just Starting for These 3 Rapid-Growth Stocks in 2026By Nathan Reiff. Originally Published: 2/2/2026. 
At a Glance - Corvus Pharmaceuticals has nearly tripled in value this year amid optimism that its atopic dermatitis drug candidate will continue to deliver strong trial results.
- Despite legal and other hurdles, New Era Energy & Digital recently noted a key achievement in its path toward providing data center capacity.
- USA Rare Earth has received around $1.6 billion in federal funding as it seeks to provide a domestic alternative to foreign rare earth minerals.
Nearly one month into 2026, the S&P 500 has been sluggish, rising just over 1% despite multiple dips in January. That middling performance, however, masks the fact that several individual companies have enjoyed a supercharged start to the year, dramatically outperforming the benchmark. Investors looking to capture rising momentum in 2026 may consider Corvus Pharmaceuticals Inc. (NASDAQ: CRVS), New Era Energy & Digital Inc. (NASDAQ: NUAI), and USA Rare Earth (NASDAQ: USAR), each of which has returned at least 56% year-to-date (YTD). Analysts Stay Bullish on Corvus With 50%+ Upside Targets As a clinical-stage biopharma, Corvus operates in an industry prone to large, rapid price swings. A recent catalyst for the stock was positive data from its drug candidate soquelitinib, being developed to treat atopic dermatitis and other conditions. In mid-January, Corvus reported promising Phase 1 results, including a 72% reduction in eczema severity among participants. Those results helped Corvus shares surge about 188% YTD. A Phase 2 trial is planned for early in the year and could push the stock higher. To bankroll the upcoming trial, Corvus initiated a $150 million equity offering to bolster its cash runway, though that move risks diluting existing shareholders. The fundraising is important because Corvus had only $67 million in cash at the end of the third quarter of 2025. The company is clearly betting on soquelitinib; the potential addressable market for atopic dermatitis is substantial. Analysts remain optimistic: six of seven analysts rate CRVS a Buy, and the consensus price target implies roughly 51% upside even after the recent rally. New Era's Data Center Pivot Makes Big Strides, Though Legal and Other Risks Remain New Era & Digital is one of the more polarizing names among energy exploration and production stocks in 2026. Shares of NUAI are up more than 114% YTD after the company announced in January a key partnership with Primary Digital Infrastructure to develop up to one gigawatt of hyperscale data-center capacity for hyperscaler clients. Earlier in the month, New Era also closed the acquisition of the remaining 50% interest in Texas Critical Data Centers, further positioning the company for its pivot into the high-demand data-center market. Those moves suggest New Era could succeed in its ambitious reorganization. However, the company faces legal scrutiny: the Rosen Law Firm has announced an investigation USA Rare Earth Looks to Fill a Significant Supply Chain Need With Government Support Rare-earth minerals are increasingly critical for many technologies, and supply-chain and trade concerns threaten to bottleneck U.S. supplies. USA Rare Earth aims to address those issues by providing a domestic alternative. The company has been buoyed in recent weeks by a $1.6 billion federal investment and additional private capital, alongside a strong cash position disclosed with its latest earnings report. The firm's rare-earth and magnet production capacity is expanding rapidly thanks to operations in Texas, and revenues are expected to grow significantly. For now, USA Rare Earth remains an early-stage company without a proven track record of profitability, which may deter some investors. Still, its 56% return YTD and a strongly optimistic analyst profile suggest meaningful upside if execution continues.
| 
Post a Comment
Post a Comment